Loncar Investment Starts China Biopharma Stock Index

00:26 EDT 16 Mar 2018 | ChinaBio Today

Loncar Investments has launched its Loncar China Biopharma Index (LCHINA), an index comprised of 32 China publicly traded biotech companies. The index, which is re-priced once a day, includes innovative life science companies that are listed in Hong Kong or on NASDAQ. Loncar said it introduced the LCHINA Index because of the growing interest in China biopharma investments, creating the need for a read on the strength of the sector. The Index started operating on February 13, 2018, at a value of 1,000. One month later it is at 1129.71, a 13% increase. More details....

Share this with colleagues:

Original Article: Loncar Investment Starts China Biopharma Stock Index


More From BioPortfolio on "Loncar Investment Starts China Biopharma Stock Index"

Quick Search


Relevant Topics

Biotechnology - Biotech
"using living things to create products or to do tasks for humans" About Biotechnology - Biotech Biotechnology is the practice of using plants, animals and micro-organisms such as bacteria, as well as biological processes - such as the ripen...

Bioscience - any of the sciences that deal with living organisms.  The study of the nature, behavior, and uses of living organisms as applied to biology. Any of the branches of natural science dealing with living things, such as their structure, b...